These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1109653)

  • 1. Editorial: Problems with digoxin.
    Br Med J; 1975 Jan; 1(5949):49-50. PubMed ID: 1109653
    [No Abstract]   [Full Text] [Related]  

  • 2. Is there a role for digoxin in atrial fibrillation without heart failure?
    Master J; Schweitzer P
    Cardiol J; 2009; 16(5):483-6. PubMed ID: 19753533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of serum digoxin assay in patient management.
    Selzer A
    J Am Coll Cardiol; 1985 May; 5(5 Suppl A):106A-110A. PubMed ID: 3886746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of digoxin effect in atrial fibrillation.
    Zener JC; Anggard EE; Harrison DC; Kalman SM
    JAMA; 1973 Apr; 224(2):239-41. PubMed ID: 4739495
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of effort tests for evaluation of the effectiveness of digitalis treatment in atrial fibrillation. Correlation with blood levels of digoxin].
    Gavrilescu S; Cristodorescu R; Deutsch G
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(4):325-38. PubMed ID: 6113645
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasma levels of cardiac glycosides and the electrocardiogram during moderately rapid and slow digitalization with beta-methyl-digoxin in normal volunteers (author's transl)].
    Belz GG; Rudofsky G; Belz G
    Dtsch Med Wochenschr; 1974 Feb; 99(8):329-32. PubMed ID: 4822437
    [No Abstract]   [Full Text] [Related]  

  • 7. Limitations of serum digitalis levels.
    Noble RJ; Rothbaum DA; Watanabe AM; Besch HR; Fisch C
    Cardiovasc Clin; 1974; 6(1):299-311. PubMed ID: 4611615
    [No Abstract]   [Full Text] [Related]  

  • 8. [Circadian aspects of the heart rate in atrial fibrillation patients: the comparative effect of digoxin and pentaformylgitoxin].
    Dei Cas L; Biasucci LM; Buia E; Frustaci A; Manca C; Metra M; Rebuzzi AG
    Cardiologia; 1983 Dec; 28(12):1019-25. PubMed ID: 6681261
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of diltiazem in the control of ventricular frequency in chronic atrial fibrillation].
    Maragno I; Santostasi G; Alitto F; Buja G; Miraglia G; Gaion RM; Dalla Volta S
    Cardiologia; 1987 Sep; 32(9):1019-24. PubMed ID: 3690595
    [No Abstract]   [Full Text] [Related]  

  • 10. The plasma digoxin concentration, red cell rubidium 86 uptake and control of ventricular rate in patients being digitalized for artrial fibrilation.
    Hibble AG; Grahame-Smith DG
    Clin Sci; 1972 Jan; 42(1):3P. PubMed ID: 5008538
    [No Abstract]   [Full Text] [Related]  

  • 11. Digoxin versus placebo for conversion of acute atrial fibrillation to sinus rhythm.
    Veloso HH; de Paola AA
    Am J Cardiol; 1999 Apr; 83(8):1300-1. PubMed ID: 10215309
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of oral verapamil in controlling ventricular rate in patients with chronic atrial fibrillation receiving digoxin.
    Manoharan S; Kaul UA; Khalilullah M
    J Assoc Physicians India; 1986 Apr; 34(4):257-9. PubMed ID: 3759820
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-blockers versus digoxin to control ventricular rate during atrial fibrillation.
    Veloso HH; de Paola AA
    J Am Coll Cardiol; 2005 Jun; 45(11):1905-6; author reply 1906-7. PubMed ID: 15936626
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma digoxin concentrations in patients with atrial fibrillation.
    Chamberlain DA; White RJ; Howard MR; Smith TW
    Br Med J; 1970 Aug; 3(5720):429-32. PubMed ID: 5454321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of heart rate in atrial fibrillation.
    Gentzler RD
    Pa Med; 1974 Jul; 77(7):61. PubMed ID: 4841137
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness of diltiazem in controlling ventricular response and improving exercise capacity in chronic atrial fibrillation. Double-blind, cross-over study].
    Vitale P; Auricchio A; De Stefano R; Agretto A; De Simone R; Vitale N; Barbato F; Iacono A
    Cardiologia; 1989 Jan; 34(1):73-81. PubMed ID: 2720716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma digoxin concentrations and digoxin toxicity in hospital patients.
    Evered DC; Chapman C
    Br Heart J; 1971 Jul; 33(4):540-5. PubMed ID: 5557468
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience with acetyl-digoxin (Sandolanid)].
    Leibetseder F
    Wien Klin Wochenschr; 1972 Mar; 84(9):148-9. PubMed ID: 5012663
    [No Abstract]   [Full Text] [Related]  

  • 19. [Circadian aspects of heart rate in patients with atrial fibrillation: comparative influence of digoxin and pentaformylgitoxin].
    Dei Cas L; Biasucci LM; Buia E; Frustaci A; Manca C; Metra M; Rebuzzi AG
    Cardiologia; 1983 Dec; 28(12):1019-25. PubMed ID: 6687204
    [No Abstract]   [Full Text] [Related]  

  • 20. [The use of digitalis glycosides in atrial fibrillation].
    Knez A; Haberl R; Steinbeck G
    Z Kardiol; 1994; 83 Suppl 5():71-3. PubMed ID: 7846948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.